Utilizing bone marrow-derived macrophages from BTK-deficient mice and PBMC from patients with X-linked agammaglobulinemia (XLA), this group found reduced IL-1β production and impaired inflammasome activation within mutant myeloid cells [18]. This evidence concerns the gene BTK and isolated agammaglobulinemia.